Direct sequencing for comprehensive screening of LDLR genetic polymorphisms among five ethnic populations

被引:0
作者
Jeong-Hyun Kim
Hyun Sub Cheong
Lyoung Hyo Kim
Hee Jung Shin
Han Sung Na
Myeon Woo Chung
Hyoung Doo Shin
机构
[1] Sogang University,Research Institute for Basic Science
[2] SNP Genetics,Department of Genetic Epidemiology
[3] Inc,Department of Toxicological Evaluation and Research National Institute of Food and Drug Safety Evaluation
[4] Osong Health Technology Administration Complex,Department of Life Science
[5] Sogang University,undefined
来源
Genes & Genomics | 2015年 / 37卷
关键词
Single nucleotide polymorphism; Lipoprotein metabolism; Pharmacogenetics; Minor allele frequency;
D O I
暂无
中图分类号
学科分类号
摘要
Low density lipoprotein receptor (LDLR) plays an important role in plasma lipoprotein metabolism and pharmacological responses. Although mutations of LDLR and their functional associations with plasma LDL cholesterol concentrations have been described, no comprehensive comparisons of LDLR variants among populations are established. The aim of this study is to define the distribution of single nucleotide polymorphisms (SNPs) of LDLR and to discover novel variants across population groups. A total of 288 DNAs from 96 Korean, 48 Chinese, 48 Japanese, 48 African-American, and 48 European-American subjects were resequenced. A total of 59 SNPs (18 in the coding regions, 37 in the introns, and 4 in the 3′-untranslated region) were identified, including eight novel variants. Polymorphisms of LDLR showed significantly different distributions in comparisons among ethnic population groups (P < 0.05, Fisher’s exact test). Moreover, almost all of these differently distributed SNPs were common variants. Notably, prevalent variations—rs1003723, rs1799898, rs688, rs5925, rs6413504 in Europeans, nonsynonymous rs11669576 (Ala391Thr) in Africans, and rs14158 in Asians—were observed. In further in silico analyses for the novel SNPs, 2 intronic variants (+17716G>A in the intron 5 and +38569A>C in the intron 16) were predicted as potential branch point sites for alternative splicing. Although this study is not free from limitations such as insufficient sample size and no functional studies on the novel SNPs, our findings provides supporting information about LDLR genetic variability among ethnic groups and pharmacogenetics studies for plasma lipoprotein metabolism.
引用
收藏
页码:247 / 255
页数:8
相关论文
共 278 条
  • [1] Adeyemo A(2012)Transferability and fine mapping of genome-wide associated loci for lipids in African Americans BMC Med Genet 13 88-670
  • [2] Bentley AR(1994)Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population Arterioscler Thromb 14 663-911
  • [3] Meilleur KG(2011)Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein Biochim Biophys Acta 1814 908-534
  • [4] Doumatey AP(2008)Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China Cancer Epidemiol Biomark Prev 17 525-33755
  • [5] Chen G(2012)Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation J Biol Chem 287 33745-47
  • [6] Zhou J(2012)LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease PLoS One 7 e30668-264
  • [7] Shriner D(1986)A receptor-mediated pathway for cholesterol homeostasis Science 232 34-131
  • [8] Huang H(2014)Genome-wide analysis of cold adaptation in indigenous Siberian populations PLoS One 9 e98076-512
  • [9] Herbert A(2012)Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (Jupiter) trial Circ Cardiovasc Genet 5 257-278
  • [10] Gerry NP(2005)Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer’s disease J Med Genet 42 129-1435